Is lidocaine spray effective for pain management during arterial or central line insertion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lidocaine Spray for Arterial/Central Line Insertion

Lidocaine spray is effective for pain management during radial arterial puncture but has not shown significant benefit for intravenous cannulation or central line insertion. 1

Effectiveness for Arterial Line Insertion

  • Lidocaine spray (10%) significantly reduces pain during radial arterial puncture compared to placebo, with median VAS pain scores of 24mm versus 33mm (p=0.011) 1
  • Application technique is important: spray should be administered six times on the site from a distance of 5cm, followed by a 5-minute wait time before arterial puncture 1
  • Topical anesthetics, including lidocaine spray, require a wait time of 5-10 minutes to achieve adequate anesthesia 2

Comparison with Other Pain Management Methods

  • Vapocoolant spray may be superior to lidocaine infiltration for arterial cannulation, with lower mean pain scores (3.4 vs 4.5) and shorter procedure times 3
  • For central venous access, intra-arterial vasodilators (calcium channel blockers and nitroglycerin) are recommended to reduce spasm but do not directly address insertion pain 4
  • Lidocaine infiltration remains a common approach for arterial line insertion, but its administration itself can cause discomfort 3

Considerations for Central Line Insertion

  • The American Heart Association recommends administration of local anesthesia and achievement of mild to moderate sedation to reduce patient anxiety, discomfort, and arterial spasm during vascular access procedures 4
  • Intravenous lidocaine infusions are not recommended for general pain management in ICU patients due to safety concerns and limited evidence of benefit 4
  • A single-center RCT of cardiac surgery patients found that IV lidocaine (1.5 mg/kg bolus followed by infusion) did not affect pain intensity compared to placebo 4

Safety Considerations

  • Patients should be warned of potential self-limiting side effects of intravascular lidocaine, such as numbness of the tongue or tinnitus 2
  • Topical lidocaine application is generally safer than systemic administration, with fewer concerns about cardiovascular and neurological toxicity 4
  • For procedures involving mucous membranes, lidocaine spray has demonstrated effectiveness, but its benefit for intact skin procedures is more variable 5

Best Practice Recommendations

  • For radial arterial puncture: Apply lidocaine 10% spray six times from 5cm distance, wait 5 minutes before puncture 1
  • For central line insertion: Consider a multimodal approach including lidocaine infiltration and appropriate sedation rather than relying solely on topical spray 4
  • For patients with high anxiety: Consider adding mild sedation (e.g., midazolam) which has been shown to reduce patient discomfort and the incidence of arterial spasm 4
  • For patients at high risk of pain: Consider alternative approaches like vapocoolant spray which may provide better pain relief with less procedural discomfort than lidocaine infiltration 3

Limitations of Current Evidence

  • Evidence specifically for central line insertion pain management is limited, with most studies focusing on arterial puncture or intravenous cannulation 1, 5
  • Lidocaine spray showed no significant benefit for intravenous cannulation in a randomized trial (VAS 18.0mm vs 21.0mm with placebo) 5
  • Self-administered lidocaine gel for other invasive procedures (e.g., IUD insertion) has not shown significant pain reduction compared to placebo 6

References

Guideline

Efficacy of Topical Anesthetics in Nasogastric Tube Insertion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Lidocaine spray as a local analgesic for intravenous cannulation: a randomized clinical trial.

European journal of emergency medicine : official journal of the European Society for Emergency Medicine, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.